Jagsonpal Pharmaceuticals Ltd.

JAGSNPHARM

₹239.31

6.8% (15.24)

Market Cap

₹1,589 Cr.

P/E

30.37

About

Jagsonpal Pharmaceutical, a leading Indian company established in 1964, is focused on the development and production of bulk drugs and pharmaceutical formulations. With a strong emphasis on research a… Read more

Jagsonpal Pharmaceutical, a leading Indian company established in 1964, is focused on the deve… Read more

Low

110

52W Range

High

328

Timeline

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statementNew

Edit rows

Forensics

10 Yes

Positive for this company

2 Neutral

Neutral for this company

5 No

Negative for this company

0 No Data

Insufficient data to analyse

Accounting & Shareholding

Contingent Liabilities

Company does not have significant contingent liabilities
Pledge

Promoters have not pledged a significant portion of their holding
Revenue Recognition

Company is converting accounting profit to cash
Depreciation Effect

Company is depreciating a greater percentage of assets. this is contributing to a reduction in net profit
Promoter Holding

Promoter has not sold any shares in the last 90 days
Retail Holding

Retail has been buying the stock which is usually a sign of exuberance
Other Income

Other income component is making ratios of the company look optically better

Price & Performance

ROE

Net profit margin is responsible for roe increase over last 10 years
Share price

Share price has increased over last 10 years due to earnings
Working Capital

Working capital of the company seems to be under control
Current vs Historic Valuation

Company is trading at a discount to 3yr historic valuations
Debt

Company should not have issues servicing its debt
ROCE Strength

Roce of the company is consistently strong
Balance Sheet Strength

Balance sheet of the company is strong. but it might have issues paying it suppliers
Capex vs ROCE

Roce of the company has decreased even without significant capex
Sales Growth

Sales of the company has grown at a slow pace
Margin Stability

Margins of the company are volatile

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Peer Comparison

Corporate Actions

Consolidated

DATE

DETAILS

Show Less

FAQs on Jagsonpal Pharmaceuticals Ltd. Business

What does Jagsonpal Pharma do?

Jagsonpal Pharmaceutical, founded in 1964, specializes in research, development, manufacturing, and distribution of bulk drugs and pharmaceutical formulations globally, aiming to establish a strong presence in the industry.

Who are the competitors of Jagsonpal Pharma?

Jagsonpal Pharma major competitors are Bliss GVS Pharma, Syncom Formulations, Lincoln Pharma, Beta Drugs, Shivalik Rasayan, Novartis, Anuh Pharma.
Market Cap of Jagsonpal Pharma is ₹1,489 Crs.
While the median market cap of its peers are ₹1,314 Crs.

Is Jagsonpal Pharma financially stable compared to its competitors?

Jagsonpal Pharma seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

View FAQ's On Shareprice

Global Leaders

Companies with a dominant global position in a product. Might be a sign of very strong moat.

Run Query

Superstar Favourites

Companies where superstar investors like Rakesh Jhunjhunwala, Asish Kacholia have invested

Run Query

Company Filing

	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release		Mar Jun Sep Dec	Jan Mar Jun Sep	Jun Sep Dec
Investor Presentation		Mar Jun Sep Dec	Jan Mar Jun Sep Dec	Feb Jun Sep Dec	Dec
Conference Call		Sep Dec
Conference Call SummaryCon Call Summary Powered by Gemini

Discussions & Analysis

Jagsonpal Pharmaceuticals Ltd.

View the discussion on ValuePickr

Ideas Dashboard

Timeline

Watchlist

Portfolio

Alerts

Research

Stock Screener

Market

Raw Material

Jagsonpal Pharmaceuticals Ltd.